Skip to main content
Equibles
OFIX logo

OFIX · Orthofix Medical Inc. · Metrics

Track OFIX — free

Use OFIX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OFIX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.92 -0.80 (-8.23%) At close · Nov 5 Play latest call Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$392.26M
Shares
40.73M
Volume · Nov 5 1.36M Avg daily vol (3M) 404.83K

OFIX metrics

97 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.92
Market cap
$392.26M

Price action

20 metrics
Price change (1W)
-3.2%
Price change (30D)
+3.3%
Price change (3M)
-6.7%
Price change (6M)
-20.3%
Price change (YTD)
-35.9%
Price change (1Y)
-34.6%
Trailing year
Price change (5Y)
-73.8%
52-week high
$16.20
52-week low
$8.64
Change from 52-week high
-40.0%
Change from 52-week low
+12.5%
Annualized volatility
49.0%
Annualized volatility (3M)
54.2%
Beta
0.9
RSI (14D)
53.2
Price vs SMA 50
+4.0%
Price vs SMA 200
-11.8%
Avg volume (3M)
402,231
Relative volume
2.9
Average dollar volume
$3.84M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
40.73M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.6×
reciprocal yield 159.3%
EV / EBITDA
38.3×
reciprocal yield 2.6%
EV / EBIT
—
P / sales
0.5×
reciprocal yield 212.4%
P / book
0.9
reciprocal yield 109.4%
FCF yield
-7.1%
TTM · current market cap
Buyback yield
16.2%
P / FCF
—
P / operating cash flow
24.1
reciprocal yield 4.1%
Earnings yield
-15.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.8×
reciprocal yield 121.7%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 103.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
29.7×
reciprocal yield 3.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
16.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-09
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
71.3%
Operating margin
-4.7%
Trailing 12 months
Net margin
-7.4%
Gross profit (TTM)
$594.12M
Operating profit (TTM)
−$39.12M
Net income (TTM)
−$61.72M
Trailing 12 months
Diluted EPS (TTM)
$-1.53
FCF margin
-3.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$20.70
Gross profit per diluted share (TTM)
$14.76
Operating profit per diluted share (TTM)
$-0.97
EBITDA per diluted share (TTM)
$0.34
Net income per diluted share (TTM)
$-1.53
Operating cash flow per diluted share (TTM)
$0.42
Free cash flow per diluted share (TTM)
$-0.68
Capital expenditures per diluted share (TTM)
$1.09
R&D per diluted share (TTM)
$1.52
Stock compensation per diluted share (TTM)
$0.71
Book value per share
$10.78

Growth

11 metrics
Revenue growth YoY
+3.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$833.19M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.6%
Year over year · more shares
Revenue CAGR (3Y)
+21.3%
Revenue CAGR (5Y)
+15.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-14.4%
Return on assets
-7.1%
Debt / equity
0.5
Current ratio
2.8
EBITDA (TTM)
$13.66M
Free cash flow (TTM)
−$27.82M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
9.6
Return on invested capital
—
Trailing 12 months
Net cash
−$130.81M
Latest balance sheet
Cash & equivalents
$103.81M
Total assets
$873.02M
Total debt
$234.62M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$16.27M
Capital expenditures (TTM)
$44.09M
R&D (TTM)
$61.41M
SG&A (TTM)
$557.80M
Stock compensation (TTM)
$28.66M
R&D / revenue
7.4%
Stock compensation / revenue
3.4%

Ownership (13F)

9 metrics
13F filers
143
13F filer change QoQ
-4
Institutional ownership
94.0%
Conviction holders (share of 13F filers)
2.1%
Crowding (high-turnover and private-fund holders)
62.8%
Private-fund adviser ownership
62.6%
Active holders' share change QoQ
+5.8%
Holder tenure
13.4
Price vs estimated holder cost
-37.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.0%

Short interest

3 metrics
Short interest
5.9%
Latest settlement · 5.8 days to cover
Days to cover
5.8d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$17,252
Insider-sentiment score
54 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 884624 CUSIP 68752M108 13F (30d) 47 filings 35 filers Visit website Investor relations